Skip to main content

and
  1. Article

    Erratum: Acquired resistance to zoledronic acid and the parallel acquisition of an aggressive phenotype are mediated by p38-MAP kinase activation in prostate cancer cells

    Correction to: Cell Death and Disease (2013) 4, e641; doi:10.1038/cddis.2013.165; published online 23 May 2013 Since the publication of this paper the authors have noticed the blots in Figure 5c displaying p-P...

    M R Milone, B Pucci, F Bruzzese, C Carbone, G Piro, S Costantini in Cell Death & Disease (2014)

  2. Article

    Open Access

    Acquired resistance to zoledronic acid and the parallel acquisition of an aggressive phenotype are mediated by p38-MAP kinase activation in prostate cancer cells

    The nitrogen-containing bisphosphonates (N-BP) zoledronic acid (ZOL) inhibits osteoclast-mediated bone resorption, and it is used to prevent skeletal complications from bone metastases. ZOL has also demonstrat...

    M R Milone, B Pucci, F Bruzzese, C Carbone, G Piro, S Costantini in Cell Death & Disease (2013)